You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Illumina, Twist Bioscience, Western Digital, and Microsoft are teaming up with others to make DNA-based data storage technologies interoperable.
Horizons Ventures led the round, joined by Airbus Ventures, bringing the MIT spinout's fundraising total to date to more than $21 million.
The North Carolina State University team is working on scaling the technology further and may form a company to develop it commercially.
Genomics England has slashed storage costs by migrating to a new file system, while NIH's All of Us research program is seeking savings from a cloud environment.
The offering of common stock will be the second for Twist this year and the third since the company made its initial public offering in October 2018.
A group of researchers devised a DNA-based storage system that uses DNA molecules to record data and produces materials with immutable memory.
French biopreservation firm Imagene will provide Twist with DNAshell technology and services to advance the storage of digital data in DNA.
Evercore analysts set a price target of $30.50 for the company and said they see opportunities in DNA synthesis, NGS tools, pharmaceuticals, and DNA data storage.
The R&D collaboration will examine a Western Digital theory that moving computational power closer to large genomic datasets can speed up analysis.
Aside from its core synthetic biology business, the company has expanded into NGS and is looking to move into drug discovery and DNA data storage.
Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.
Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.
A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.
In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.